News & Perspective

Nov 30, 2007

Nov 30, 2007

UN: H5N1 responses improving, but threat persists

(CIDRAP News) – Many countries have improved their responses to H5N1 avian influenza outbreaks in poultry in the past year, but the disease remains entrenched in six countries, according to a new report from the United Nations and the World Bank.

Nov 29, 2007

Nov 29, 2007

UK: H5N1 outbreak may be linked to wild birds, lax biosecurity

(CIDRAP News) – The initial epidemiologic report, released today, on the United Kingdom's recent outbreaks of H5N1 avian influenza in Suffolk said the source of the virus is unknown but could have been wild birds.

Nov 19, 2007

Nov 19, 2007

H5N1 hits second farm in UK

(CIDRAP News) – A second turkey farm in the Suffolk-Norfolk area of England has been hit by the H5N1 avian influenza virus, though the flock there appeared healthy, British authorities announced today.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Nov 15, 2007

H5N1 suspected at second British farm

(CIDRAP News) – Veterinary officials in England today said they suspected H5N1 avian influenza at another poultry farm, as authorities in Saudi Arabia stamped out a large poultry flock following confirmation of the virus at a farm near the nation's capital.

Nov 13, 2007

Nov 13, 2007

British officials confirm H5N1 in turkey outbreak

(CIDRAP News) – The avian influenza virus found this week in turkeys at a farm in Suffolk, England, is the lethal H5N1 variety, veterinary officials announced today.

Oct 31, 2007

Oct 31, 2007

THE PANDEMIC VACCINE PUZZLE Part 5: What role for prepandemic vaccination?

Editor's note: This is the fifth in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Oct 26, 2007

Oct 26, 2007

THE PANDEMIC VACCINE PUZZLE Part 2: Vaccine production capacity falls far short

Editor's note: This is the second in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Oct 04, 2007

Oct 04, 2007

House committee airs safety concerns about biodefense labs

(CIDRAP News) – A US House of Representatives committee today explored problems at the nation's biodefense labs, including a lack of coordinated federal oversight and even a lack of knowledge of how many high-containment labs exist.

These concerns have been highlighted recently by aggressive efforts from the Sunshine Project, a watchdog group that monitors biodefense research safety, and by other media reports.

Sep 25, 2007

Sep 25, 2007

Wisconsin lab broke Ebola rules, watchdog group says

(CIDRAP News) – Researchers at the University of Wisconsin at Madison (UW-Madison) worked on Ebola virus genetic material in a lab that lacked the required security measures, and federal agencies responsible for monitoring compliance didn't notice the problem, a watchdog group that monitors biodefense research safety reported recently.

Pages

Sort Results

 

Narrow results

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»